DEUTSCHE BANK AG\ - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 138 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,969,098
-18.6%
294,775
+2.2%
0.00%0.0%
Q2 2023$2,418,879
+8.7%
288,305
+28.7%
0.00%0.0%
Q1 2023$2,224,856
+39.3%
224,054
-2.4%
0.00%0.0%
Q4 2022$1,597,000
+30.4%
229,4540.0%0.00%0.0%
Q3 2022$1,225,000
+33.7%
229,4540.0%0.00%0.0%
Q2 2022$916,000
-30.3%
229,454
-22.4%
0.00%0.0%
Q1 2022$1,315,000
+26.0%
295,827
+13.4%
0.00%
Q4 2021$1,044,000
-54.2%
260,976
+0.6%
0.00%
-100.0%
Q3 2021$2,278,000
-22.8%
259,424
-0.3%
0.00%0.0%
Q2 2021$2,949,000
-17.2%
260,324
-13.1%
0.00%
-50.0%
Q1 2021$3,560,000
+73.2%
299,6330.0%0.00%
+100.0%
Q4 2020$2,055,000
+53.9%
299,633
+66.3%
0.00%0.0%
Q3 2020$1,335,000
+302.1%
180,224
+126.5%
0.00%
Q2 2020$332,000
+730.0%
79,557
+383.4%
0.00%
Q1 2020$40,000
-79.5%
16,457
-51.5%
0.00%
Q4 2019$195,000
+146.8%
33,902
+123.6%
0.00%
Q3 2019$79,000
-50.6%
15,160
-43.6%
0.00%
Q2 2019$160,000
-50.3%
26,882
-25.0%
0.00%
Q1 2019$322,000
-1.8%
35,848
-9.6%
0.00%
Q4 2018$328,000
-67.1%
39,658
-45.1%
0.00%
Q3 2018$996,000
+124.3%
72,284
+29.2%
0.00%
Q2 2018$444,000
+3936.4%
55,944
+3190.8%
0.00%
Q4 2017$11,000
-80.7%
1,700
-78.8%
0.00%
Q3 2017$57,000
+46.2%
8,000
+0.5%
0.00%
Q1 2017$39,0007,961
+27351.7%
0.00%
Q2 2015$0
-100.0%
29
-98.9%
0.00%
Q1 2015$25,0002,530
+3514.3%
0.00%
Q2 2014$0700.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Prosight Management, LP 473,446$5,625,0004.61%
Knoll Capital Management, LLC 569,405$6,765,0004.41%
SILVERARC CAPITAL MANAGEMENT, LLC 321,879$3,824,0002.09%
First Light Asset Management, LLC 2,624,001$31,173,0002.07%
Mesirow Financial Investment Management, Inc. 63,634$756,0002.06%
Ghost Tree Capital, LLC 650,000$7,722,0001.82%
Altium Capital Management LP 548,225$6,513,0001.81%
Perceptive Advisors 8,703,879$103,402,0001.31%
Affinity Asset Advisors, LLC 300,000$3,564,0001.21%
Avidity Partners Management LP 2,552,000$30,318,0000.84%
View complete list of ALDEYRA THERAPEUTICS INC shareholders